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reasons which the authors state. I do hope that their
results will not reverse this trend. It has been
suggested that perhaps patients in the younger age
group do not respond so well to this type of manage-
ment but this has not been our experience or those of
others using the same type of dilator.' Csendes and
colleagues state that the procedure is painful but this is
not something our patients have complained of when
the procedure is carried out under diazepam sedation
which they do not use. The main danger of pneumatic
dilatation, which the authors rightly emphasise, is
perforation of the oesophagus. This complication can
nearly always be managed conservatively but it must
be emphasised that in this gastrointestinal procedure
as in many others medicosurgical collaboration is
important.
Lastly, the authors emphasise the problem of
individuality of the different dilatation methods and
the consequent difficulty of comparing these. This
observation may be correct but I do not think it should
be considered an impossible task. There are enough
Units carrying out the procedure for such a project to
at least be considered.
A W DELLIPIANI
North Tees General Hospital,
Hardwick,
Stockton-on- Tees,
Cleveland TSI98PE
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Reply
SIR,-We are grateful to Dr Dellipiani for his
interesting comments.
The inflationary pressures that we use vary from 12
to 15 pounds per square inches (250 to 300 mmHg
metric) which we believe are high pressures.
We have not used diazepam sedation because the
pain that is usually seen with pneumatic dilatation,
could be masked. We always perform radiological
control of dilatation, however, and could therefore
use diazepam.
Cooperative randomised studies are needed, but it
will not be an easy task.
A7rFILA CSENDES
Hospital Clinico
'Jose Joaquin Aguirre',
Santiago, Chile
Mediators of vasopressin induced natriuresis in
cirrhosis - possible role of atrial natriuretic factor
SIR, - Lenz etal (Gut 1989; 30: 90-6) recently reported
increased natriuresis and diuresis in patients with
cirrhosis and ascites after vasopressin infusion. The
authors suggested suppression of sympathetic
nervous system activity as an important mediator of
the beneficial effects of vasopressin. Neither this
nor other mechanisms discussed, however, could
satisfactorily explain the observed improvement of
renal function.
For further elucidation of the interesting results
reported by Lenz et al, investigation of the atrial
natriuretic factor (ANF) might be helpful. The role
of this first well defined natriuretic hormone in
volume retention of cirrhosis is being controversely
discussed,' with some authors reporting a relative
deficiency of ANF plasma concentrations or impair-
ment of ANF release in patients with cirrhosis and
ascites.' In rats, infusion of vasopressin has been
shown to increase ANF plasma concentrations3 and
ANF-induced natriuresis was found potentiated by
vasopressin administration.' Observations of an
inhibition of vasopressin release by ANFPh lend
further support to the contention that both hormonal
systems are closely related. Thus, determination of
ANF plasma concentrations might reveal ANF as a
mediator of the vasopressin induced natriuresis in
patients with cirrhosis and ascites.
ALEXANDER L GERBES
Department of Medicine II,
Klinikum Grosshadern,
Uniiversity of Munich,
Munich, Federal Republic of Germany
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pressin concentration in human subjects. Clin Endocrinol
1986; 25:181-7.
Reply
SIR,-We appreciate the helpful and very positive
comments made by Dr Gerbes. Indeed there is
evidence from animal models, that both ANF and
vasopressin influence the action or level of activity of
the other and interact at the level of the kidney.'
Although vasopressin itself, in pharmacological
doses, is a potent diuretic that most likely exerts this
effect by directly inhibiting sodium reabsorption at a
point in the nephron distal to the proximal tube.'
Furthermore it has been shown, that vasopressin
analogues may stimulate ANF secretion in cirrhotic
patients4 and infusion ANF has a natriuretic effect at
least in some cirrhotic patients.' Therefore orni-
pressin induced stimulation of ANF secretion and
enhancement ofANF action at the level of the kidney
News
Lady Sobell Gastrointestinal Unit
The official opening on 5th June 1989 by H R H
Princess Alexandra of the new Lady Sobell Gastro-
intestinal Unit at Wexham Park Hospital, Slough
marked the successful culmination of a major fund
raising campaign, which raised £1 5 million in three
years, to build, equip and endow a single storey,
320 m) building comprising an endoscopy suite of two
rooms, one with a full x-ray unit, recovery and
waiting areas, seminar room, two research labora-
tories, four offices and appropriate ancillary accom-
modation. The new unit, headed by Dr P I Reed, will
allow development of a fully integrated gastro-
intestinal service to serve a large health district and
expand research activities.
Sir Francis Avery Jones BSG Research Award 1990
A three page summary of personal research work is
invited by the Education Committee of the British
Society of Gastroenterology who will recommend to
Council the recipient of the 1990 Award. A biblio-
could be an important factor of natriuresis in our
patients.
K lENZ
I Med Unit' Klinik, Lazaretlg. 14,
A 1090 Wien,
Auistria
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graphy may also be submitted if desired. The Award
consists of a medal and £100 prize. Entrants must be
40 years or less on 31 December 1990 but need not be
a member of the BSG. All (or a substantial part) of
the work must have been performed in the UK or
Eire. The recipient will be required to deliver a 40
minute lecture at the Plenary Session of the Spring
meeting of the Society at the University of Warwick
in 1990. Applications (15 COPIES) should be made
to: The Honorary Secretary, BSG, 3 St Andrew's
Place, Regent's Park, London, NW1 4LB, BY 1
DECEMBER 1989.
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